FDA reviewing Medac's injectable methotrexate

FDA accepted an NDA from Medac GmbH (Wedel, Germany) for MPI-2505 -- an autopen containing subcutaneous injectable methotrexate -- to treat rheumatoid arthritis (RA), polyarticular-course juvenile RA ...